Ed Deng is the CEO of Health2Sync, which he co-founded after witnessing many in his family battle diabetes and learning what works in managing diabetes effectively. Ed is also a Partner of Verge HealthTech Fund, world's first seed stage healthtech fund investing globally. Ed serves on the Investor Advisory Board of the Digital Therapeutics Alliance. Ed started his career as an Investment Banker at Lehman Brothers’s Technology Mergers & Acquisitions Group. Ed obtained a BS in Commerce-Finance from McIntire School of Commerce at The University of Virginia, where he currently serves on the Global Advisory Board.